Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AdaptHealth Corp.AHCO · Entity 5183 | Director · Chief Executive Officer | May 08, 2023 | May 10, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AdaptHealth Corp.
Report date May 08, 2023 · Filed May 10, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001 per share ("Common Stock")SEC Table I · non-derivative | Direct | 743,534 |
Reported balance
After 2023-05-08 transaction · row 1
1 source rowRow 1 · 2023-05-08 · Exercise / conversion · Acquired 559,071 · Balance 743,534 |
| Common StockSEC Table I · non-derivative | Direct | 398,315 |
Reported balance
After 2023-05-08 transaction · row 2
1 source rowRow 2 · 2023-05-08 · Tax withholding · Disposed 345,219 · Balance 398,315 F1: Represents a "net exercise" of outstanding stock options. The reporting person received 213,852 shares of Common Stock on net exercise of options to purchase 559,071 shares of Common Stock. The Company withheld 345,219 shares of Common Stock underlying the options for payment of the exercise price and tax withholdings. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.38 · Expires 2026-08-01 | Direct | 0 |
Reported balance
After 2023-05-08 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-05-08 · Exercise / conversion · Disposed 559,071 · Balance 0 F3: On December 1, 2020, the Issuer entered into an Agreement and Plan of Merger (the "Merger Agreement") with AH Apollo Merger Sub Inc., AH Apollo Merger Sub II Inc., Peloton Equity, LLC and AeroCare Holdings, Inc. ("AeroCare"). The effective time of the merger (the "AeroCare Merger") occurred on February 1, 2021, at which time the outstanding shares of the Common Stock and options to acquire Common Stock of AeroCare were converted into the right to receive, among other things, shares of the Issuer's Common Stock and Series C Preferred Stock and options to acquire Common Stock, respectively, pursuant to the Merger Agreement. F4: Options were fully vested as of the effective time if the AeroCare Merger. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 3,576,927 |
Reported balance
Holding disclosure · report date 2023-05-08 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 3,576,927 F2: Securities held directly by the Stephen P. Griggs Revocable Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a "net exercise" of outstanding stock options. The reporting person received 213,852 shares of Common Stock on net exercise of options to purchase 559,071 shares of Common Stock. The Company withheld 345,219 shares of Common Stock underlying the options for payment of the exercise price and tax withholdings.
F2: Securities held directly by the Stephen P. Griggs Revocable Trust.
F3: On December 1, 2020, the Issuer entered into an Agreement and Plan of Merger (the "Merger Agreement") with AH Apollo Merger Sub Inc., AH Apollo Merger Sub II Inc., Peloton Equity, LLC and AeroCare Holdings, Inc. ("AeroCare"). The effective time of the merger (the "AeroCare Merger") occurred on February 1, 2021, at which time the outstanding shares of the Common Stock and options to acquire Common Stock of AeroCare were converted into the right to receive, among other things, shares of the Issuer's Common Stock and Series C Preferred Stock and options to acquire Common Stock, respectively, pursuant to the Merger Agreement.
F4: Options were fully vested as of the effective time if the AeroCare Merger.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 08, 2023 Filed May 10, 2023 19:13 UTC | AdaptHealth Corp. AHCO · Entity 5183 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 559,071 | $0.00 Strike: $4.38 | $0.00 |
DisclosureSEC source: 0001104659-23-058612 · tm2315231-1_4seq1.xml · derivative · entry 4 GRIGGS STEPHEN P · CIK 0001275762 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 559,071 shares Expires 2026-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On December 1, 2020, the Issuer entered into an Agreement and Plan of Merger (the "Merger Agreement") with AH Apollo Merger Sub Inc., AH Apollo Merger Sub II Inc., Peloton Equity, LLC and AeroCare Holdings, Inc. ("AeroCare"). The effective time of the merger (the "AeroCare Merger") occurred on February 1, 2021, at which time the outstanding shares of the Common Stock and options to acquire Common Stock of AeroCare were converted into the right to receive, among other things, shares of the Issuer's Common Stock and Series C Preferred Stock and options to acquire Common Stock, respectively, pursuant to the Merger Agreement. F4 · derivative.exercise_date: Options were fully vested as of the effective time if the AeroCare Merger. Read SEC document |
| May 08, 2023 Filed May 10, 2023 19:13 UTC | AdaptHealth Corp. AHCO · Entity 5183 | Tax withholdingCommon Stock | 345,219 | $11.86 | $4,094,297.34 |
DisclosureSEC source: 0001104659-23-058612 · tm2315231-1_4seq1.xml · nonDerivative · entry 2 GRIGGS STEPHEN P · CIK 0001275762 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 398,315 F1 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 213,852 shares of Common Stock on net exercise of options to purchase 559,071 shares of Common Stock. The Company withheld 345,219 shares of Common Stock underlying the options for payment of the exercise price and tax withholdings. Read SEC document |
| May 08, 2023 Filed May 10, 2023 19:13 UTC | AdaptHealth Corp. AHCO · Entity 5183 | Exercise / conversionCommon Stock, par value $0.0001 per share ("Common Stock") | 559,071 | $4.38 | $2,448,730.98 |
DisclosureSEC source: 0001104659-23-058612 · tm2315231-1_4seq1.xml · nonDerivative · entry 1 GRIGGS STEPHEN P · CIK 0001275762 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 743,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 18:24 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantCommon Stock | 77,938 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-031875 · tm235381-17_4seq1.xml · nonDerivative · entry 1 GRIGGS STEPHEN P · CIK 0001275762 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,463 F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting. Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 16:46 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 32,342 | $15.44 | $499,506.02 |
DisclosureSEC source: 0001104659-22-030639 · tm228192-4_4seq1.xml · nonDerivative · entry 1 GRIGGS STEPHEN P · CIK 0001275762 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,576,927 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.30 to $15.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). F2 · ownership.nature: Securities held directly by the Stephen P. Griggs Revocable Trust. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 16:37 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantCommon Stock | 7,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-025203 · tm225219-13_4seq1.xml · nonDerivative · entry 1 GRIGGS STEPHEN P · CIK 0001275762 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,525 Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 17:04 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantCommon Stock | 81,617 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-011417 · tm225219-3_4seq1.xml · nonDerivative · entry 1 GRIGGS STEPHEN P · CIK 0001275762 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,875 F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 18:28 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 50,000 | $19.42 | $970,995.00 |
DisclosureSEC source: 0001104659-21-145995 · tm2131927-3_4seq1.xml · nonDerivative · entry 1 GRIGGS STEPHEN P · CIK 0001275762 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,544,585 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.355 to $19.47, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). F2 · ownership.nature: Securities held directly by the Stephen P. Griggs Revocable Trust. Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 19:52 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantCommon Stock | 13,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-125921 · tm2129900-3_4seq1.xml · nonDerivative · entry 1 GRIGGS STEPHEN P · CIK 0001275762 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,258 Read SEC document |
| May 20, 2021 Filed May 24, 2021 16:18 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseClass A Common Stock | 4,000 | $24.14 | $96,540.00 |
DisclosureSEC source: 0001104659-21-071199 · tm2116205-2_4seq1.xml · nonDerivative · entry 1 GRIGGS STEPHEN P · CIK 0001275762 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.93 to $24.34, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). Read SEC document |
| February 02, 2021 Filed Feb 3, 2021 20:16 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantEmployee Stock Option (right to buy) · Derivative | 90,090 | $0.00 Strike: $53.72 | $0.00 |
DisclosureSEC source: 0001567619-21-002151 · doc1.xml · derivative · entry 3 GRIGGS STEPHEN P · CIK 0001275762 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,090 Underlying: Class A Common Stock · 90,090 shares Expires 2026-01-28 F3 · derivative.exercise_date: Options vest in three equal annual installments, beginning on January 28, 2022. Read SEC document |
| February 02, 2021 Filed Feb 3, 2021 20:16 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantEmployee Stock Option (right to buy) · Derivative | 77,700 | $0.00 Strike: $48.17 | $0.00 |
DisclosureSEC source: 0001567619-21-002151 · doc1.xml · derivative · entry 2 GRIGGS STEPHEN P · CIK 0001275762 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,700 Underlying: Class A Common Stock · 77,700 shares Expires 2026-01-28 F2 · derivative.exercise_date: Options vest in three equal annual installments, beginning on January 28, 2022. Read SEC document |
| February 02, 2021 Filed Feb 3, 2021 20:16 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantEmployee Stock Option (right to buy) · Derivative | 66,600 | $0.00 Strike: $42.61 | $0.00 |
DisclosureSEC source: 0001567619-21-002151 · doc1.xml · derivative · entry 1 GRIGGS STEPHEN P · CIK 0001275762 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,600 Underlying: Class A Common Stock · 66,600 shares Expires 2026-01-28 F1 · derivative.exercise_date: Options vest in three equal annual installments, beginning on January 28, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.